Le, Ethan
Moadab, Fatemeh
Wang, Xiaoxing
Najjar, Rayan
Bays, Alison
Hastie, Kathryn M.
Shek, Jeremy
Saphire, Erica Ollmann
Mustelin, Tomas
Funding for this research was provided by:
Center for Scientific Review (R01 AR074939, R01 AR081654, R01 AI186337, R21 AR077266, T32 AR007108, K08 AR082939)
Kyowa Kirin Inc. (KKNA) Accelerator Fund
Article History
Received: 2 April 2025
Accepted: 20 August 2025
First Online: 30 September 2025
Declarations
:
: The study was approved by the University of Washington Institutional Review Board. Informed written consent was obtained from all participants according to the Declaration of Helsinki.
: Not applicable.
: TM reports consulting fees from Cugene, ROME Therapeutics, Evolved, and Codify Therapeutics.